|
 |
|
|||||||
|
|||||||||
Diabetes 51:3400-3407, 2002
© 2002 by the American Diabetes Association, Inc.
Activating Transcription Factor-2 Mediates Transcriptional Regulation of Gluconeogenic Gene PEPCK by Retinoic Acid
1 Hormone Research Center, Chonnam National University, Kwangju, Korea
2 Department of Chemistry, Chonnam National University, Kwangju, Korea
3 Department of Biochemistry, College of Oriental Medicine, Dong-Eui University, Busan, Korea
4 Department of Molecular Biology, Pusan National University, Busan, Korea
All-trans-retinoic acid (RA) is known to increase the rate of transcription of the PEPCK gene upon engagement of the RA receptor (RAR). RA also mediates induction of specific gene transcription via several signaling pathways as a nongenomic effect. Here we show that RA upregulation of PEPCK promoter activity requires the cAMP response element (CRE)-1 in addition to the RA-response element and that activating transcription factor-2 (ATF-2) binds the CRE element to mediate this effect. Furthermore, we show that RA treatment potentiates ATF-2-dependent transactivation by inducing specific phosphorylation of ATF-2 by p38ß kinase. ATF-2 activation by RA blocked the inhibitory intramolecular interaction of ATF-2 amino and carboxyl terminal domains in a p38ß kinase-dependent manner. Consistent with these results, RA treatment increased the DNA binding activity of ATF-2 on the PEPCK CRE-1 sequence. Taken together, the data suggest that RA activates the p38ß kinase pathway leading to phosphorylation and activation of ATF-2, thereby enhancing PEPCK gene transcription and glucose production.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Dey, P. K. De, M. Wang, H. Zhang, E. A. Dobrota, K. A. Robertson, and D. L. Durden CSK Controls Retinoic Acid Receptor (RAR) Signaling: a RAR-c-SRC Signaling Axis Is Required for Neuritogenic Differentiation Mol. Cell. Biol., June 1, 2007; 27(11): 4179 - 4197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Okamura, H. Shimizu, T. Nagao, R. Ueda, and S. Ishii ATF-2 Regulates Fat Metabolism in Drosophila Mol. Biol. Cell, April 1, 2007; 18(4): 1519 - 1529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Corbetta, R Angioni, A Cattaneo, P Beck-Peccoz, and A Spada Effects of retinoid therapy on insulin sensitivity, lipid profile and circulating adipocytokines Eur. J. Endocrinol., January 1, 2006; 154(1): 83 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Cao, Q. F. Collins, T. C. Becker, J. Robidoux, E. G. Lupo Jr., Y. Xiong, K. W. Daniel, L. Floering, and S. Collins p38 Mitogen-activated Protein Kinase Plays a Stimulatory Role in Hepatic Gluconeogenesis J. Biol. Chem., December 30, 2005; 280(52): 42731 - 42737. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. B. Scribner, D. P. Odom, and M. M. McGrane Vitamin A Status in Mice Affects the Histone Code of the Phosphoenolpyruvate Carboxykinase Gene in Liver J. Nutr., December 1, 2005; 135(12): 2774 - 2779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Khidekel, S. B. Ficarro, E. C. Peters, and L. C. Hsieh-Wilson Exploring the O-GlcNAc proteome: Direct identification of O-GlcNAc-modified proteins from the brain PNAS, September 7, 2004; 101(36): 13132 - 13137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kravets, Z. Hu, T. Miralem, M. D. Torno, and M. D. Maines Biliverdin Reductase, a Novel Regulator for Induction of Activating Transcription Factor-2 and Heme Oxygenase-1 J. Biol. Chem., May 7, 2004; 279(19): 19916 - 19923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hong, H. M. Choi, M. J. Park, Y. H. Kim, Y. H. Choi, H. H. Kim, Y. H. Choi, and J. Cheong Activation and Interaction of ATF2 with the Coactivator ASC-2 Are Responsive for Granulocytic Differentiation by Retinoic Acid J. Biol. Chem., April 23, 2004; 279(17): 16996 - 17003. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |